医学
肝硬化
酒精性肝炎
酒精性肝病
发病机制
胃肠病学
疾病
内科学
作者
Winston Dunn,Vijay H. Shah
标识
DOI:10.1016/j.cld.2016.02.004
摘要
Alcoholic liver disease includes a broad clinical-histological spectrum from simple steatosis, cirrhosis, acute alcoholic hepatitis with or without cirrhosis to hepatocellular carcinoma as a complication of cirrhosis. The pathogenesis of alcoholic liver disease can be conceptually divided into (1) ethanol-mediated liver injury, (2) inflammatory immune response to injury, (3) intestinal permeability and microbiome changes. Corticosteroids may improve outcomes, but this is controversial and probably only impacts short-term survival. New pathophysiology-based therapies are under study, including antibiotics, caspase inhibition, interleukin-22, anakinra, FXR agonist and others. These studies provide hope for better future outcomes for this difficult disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI